Toll-like receptor engagement could also be involved in IL-1β induction [43,44], with induction of primary necrosis and haemorrhage in the tumour (evident after ingenol mebutate treatment in mice [60], see also Figure I in S1 File) potentially providing self-derived Toll-like receptor agonists [61]. The gene discussed is IL1B; the disease is neoplasm.